Preventive administration of Bifidobacterium animalis subsp. lactis HEM20–01 attenuates the development of atopic dermatitis-like inflammation in mice, along with gut microbial and succinate alterations
5 affiliations
- 1Department of Biomedical Science, Graduate School, CHA University
- 2Department of Medicine, CHA University School of Medicine
- 3HEM Pharma Inc.
- 4College of Pharmacy and Institute of Pharmaceutical Sciences, CHA University
- 5Department of Dermatology, Bundang CHA Medical Center, CHA University School of Medicine
Abstract
Background: Atopic dermatitis (AD) is a chronic inflammatory skin disorder frequently accompanied by gut dysbiosis and neurobehavioral comorbidities, but the microbial metabolites mediating gut–skin crosstalk remain unclear. We investigated whether preventive administration of Bifidobacterium animalis subsp. lactis HEM20–01 attenuates the development of AD-like phenotypes and characterized the accompanying gut microbiome, succinate, intestinal, and behavioral alterations.
Methods: HEM20–01 was orally administered to NC/Nga mice beginning 2 weeks before house dust mite (HDM) induction and continued throughout the 4-week induction period. Cutaneous and intestinal inflammation were assessed by histology, gene expression, and multiplex cytokine analysis, and behavior by the open field test. Fecal microbiota composition and metabolite profiles were analyzed by 16S rRNA gene sequencing and gas chromatography–time-of-flight mass spectrometry (GC-TOF-MS)-based metabolomics. Exogenous succinate was administered in an independent MC903-induced dermatitis model to test whether succinate can aggravate these responses.
Results: HDM-induced AD-like mice showed activation of the intestinal succinate receptor 1 (SUCNR1)–tuft cell–IL-25 axis and enrichment of the putative succinate-associated family Rikenellaceae and its genus Alistipes , together with elevated fecal and plasma succinate. Preventive HEM20–01 administration attenuated the development of cutaneous and intestinal inflammatory phenotypes. HEM20-01-treated mice also showed a lower relative abundance of putative succinate-associated taxa (Bacteroidaceae, Rikenellaceae, Christensenellaceae, Bacteroides , and Alistipes ), lower circulating succinate levels, reduced activation of SUCNR1–tuft cell–IL-25-related signaling, and attenuated behavioral and hippocampal serotonergic alterations compared with untreated AD-like mice. In a separate MC903-induced dermatitis model, succinate supplementation exacerbated cutaneous and intestinal inflammation.
Conclusions: Preventive HEM20–01 administration attenuates the development of AD-like phenotypes and associated behavioral alterations, accompanied by changes in gut microbiome composition, lower circulating succinate, and intestinal inflammatory signaling.
Related
- Development and psychometric validation of Mpox knowledge and preventive behavior measures in the Turkish population
- Prophage induction contributes to alterations in the gut phageome during intestinal inflammation
- Development of immunological reagents for the identification of biomarkers of inflammation in the common marmoset
- Low-molecular-weight Ulva lacinulata extract exhibiting anti-inflammatory and pro-autophagic activities in RAW 264.7 macrophages: a promising candidate for the development of active ingredients targeting low-grade inflammation
- Potential mechanisms of Bifidobacterium-mediated synergistic antibiotic eradication of drug-resistant Helicobacter pylori
BibTeX
@article{jang2026preventive,
title = {{Preventive administration of Bifidobacterium animalis subsp. lactis HEM20–01 attenuates the development of atopic dermatitis-like inflammation in mice, along with gut microbial and succinate alterations}},
author = {Young Su Jang and Hyeongjin Na and Hyo-Jin Lee and Yeojin Bang and Jae-Sang Ryu and Haivin Kim and Dahye Seo and Inseon Sim and Dong Ho Suh and Eun Sung Jung and Yosep Ji and Dong Hyun Kim and Hyun Jin Choi and Jung U. Shin},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1915780},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1915780/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Preventive administration of Bifidobacterium animalis subsp. lactis HEM20–01 attenuates the development of atopic dermatitis-like inflammation in mice, along with gut microbial and succinate alterations
AU - Young Su Jang
AU - Hyeongjin Na
AU - Hyo-Jin Lee
AU - Yeojin Bang
AU - Jae-Sang Ryu
AU - Haivin Kim
AU - Dahye Seo
AU - Inseon Sim
AU - Dong Ho Suh
AU - Eun Sung Jung
AU - Yosep Ji
AU - Dong Hyun Kim
AU - Hyun Jin Choi
AU - Jung U. Shin
PY - 2026
DA - 2026/10/13
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1915780
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1915780/full
AB - Background: Atopic dermatitis (AD) is a chronic inflammatory skin disorder frequently accompanied by gut dysbiosis and neurobehavioral comorbidities, but the microbial metabolites mediating gut–skin crosstalk remain unclear. We investigated whether preventive administration of Bifidobacterium animalis subsp. lactis HEM20–01 attenuates the development of AD-like phenotypes and characterized the accompanying gut microbiome, succinate, intestinal, and behavioral alterations. Methods: HEM20–01 was orally administered to NC/Nga mice beginning 2 weeks before house dust mite (HDM) induction and continued throughout the 4-week induction period. Cutaneous and intestinal inflammation were assessed by histology, gene expression, and multiplex cytokine analysis, and behavior by the open field test. Fecal microbiota composition and metabolite profiles were analyzed by 16S rRNA gene sequencing and gas chromatography–time-of-flight mass spectrometry (GC-TOF-MS)-based metabolomics. Exogenous succinate was administered in an independent MC903-induced dermatitis model to test whether succinate can aggravate these responses. Results: HDM-induced AD-like mice showed activation of the intestinal succinate receptor 1 (SUCNR1)–tuft cell–IL-25 axis and enrichment of the putative succinate-associated family Rikenellaceae and its genus Alistipes , together with elevated fecal and plasma succinate. Preventive HEM20–01 administration attenuated the development of cutaneous and intestinal inflammatory phenotypes. HEM20-01-treated mice also showed a lower relative abundance of putative succinate-associated taxa (Bacteroidaceae, Rikenellaceae, Christensenellaceae, Bacteroides , and Alistipes ), lower circulating succinate levels, reduced activation of SUCNR1–tuft cell–IL-25-related signaling, and attenuated behavioral and hippocampal serotonergic alterations compared with untreated AD-like mice. In a separate MC903-induced dermatitis model, succinate supplementation exacerbated cutaneous and intestinal inflammation. Conclusions: Preventive HEM20–01 administration attenuates the development of AD-like phenotypes and associated behavioral alterations, accompanied by changes in gut microbiome composition, lower circulating succinate, and intestinal inflammatory signaling.
SN - 1664-3224
ER -